2 completed, 2 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Unknown 2 |
Follow Olanzapine 5 MG: new trials by email Literature Review of Olanzapine 5 MG trials Research Report on Olanzapine 5 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olanzapine for Cancer Related Anorexia-cachexia Syndrome Olanzapine 2.5 MG, Olanzapine 5 MG, Placebo - Anorexia, Cachexia | Phase 3 | Unknown | Mahidol University | 138 | 2024-01-22 | 2024-07-24 |
| Olanzapine Anorexia Cachexia Olanzapine 5 MG, Placebo - Anorexia | Phase 3 | Completed | Cairo University | 164 | 2021-12-25 | 2024-10-03 |
| Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants Olanzapine 5 MG, Placebo - Chemotherapy-induced Nausea and Vomiting | Phase 3 | Completed | UNC Lineberger Comprehensive Cancer Center | 91 | 2020-08-18 | 2023-05-09 |
| Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic Chemotherapy aprepitant, olanzapine 10 mg, olanzapine 5 mg - Antiemetic for Highly Emetogenic Chemotherapy | Phase 3 | Unknown | Mahidol University | 147 | 2019-03-01 | 2019-03-15 |
Anorexia (2) · Cachexia (1) · Nausea (1) · Vomiting (1)
Mahidol University (2) · Cairo University (1) · UNC Lineberger Comprehensive Cancer Center (1)
Thailand (2) · Egypt (1) · United States (1)
Jonathan Ptachcinski, PharmD (1) · S Al Sirafy, Professor (1) · Suthinee Ithimakin, MD (1)